Literature DB >> 6288651

In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties.

D Greenwood, A Eley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6288651     DOI： 10.1093/jac/10.2.117

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam.

Authors:  F Moosdeen; J D Williams; S Yamabe
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

Review 2.  Sulbactam/ampicillin in the treatment of lower respiratory infections.

Authors:  M A Castellano
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.

Authors:  D M Campoli-Richards; R N Brogden
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

4.  Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.

Authors:  D L Hemsell
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.

Authors:  H M Wexler; B Harris; W T Carter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.